ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011

Community Centers Group Lines Up A Speaker

January 10, 1975

In Brief: NCAB Committee Recommends Joint NCI/Vendor PDQ Promotion; Frank Schabel Dies In Vienna

September 9, 1983

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

June 29, 2001

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996